Xudong Wei

机构：China XD Group (China)

发表论文 5 篇

代表论文

• Abstract 1704: Method development of purity and assay HPLC method for unstable antibody-drug conjugate linker regulated starting material BCN-OH (2026 · Cancer Research)
• Abstract 1705: Compatibility study of routine chromatographic analytical testing of antibody-drug conjugate payload-linkers (2026 · Cancer Research)
• Abstract 290: Scientific justification for setting up an appropriate specification of residual solvent based on ICH guideline. (2026 · Cancer Research)
• Abstract 4435: Transforming ADC development with novel linker architectures and payload optimization (2026 · Cancer Research)
• Abstract 1694: Application of tangential flow-filtration (TFF) to enable solvent exchange and precipitation process for the production of payload-linkers of antibody-drug conjugates (2026 · Cancer Research)